Arlington, MA, United States of America

Bo Peng

This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ironwood Pharmaceuticals, Inc.. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo Peng. Retrieved from https://idiyas.com/inventor/bo-peng-hp4bqvxy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 9.9

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bo Peng: Pioneering Inventor from Arlington, MA

Introduction: Bo Peng is a distinguished inventor hailing from Arlington, MA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Bo Peng holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and innovative spirit.

Career Highlights: With over two decades of experience in the tech industry, Bo Peng has worked for leading companies such as Tech Innovators Inc. and Research Dynamics, where he spearheaded projects that have revolutionized the way we interact with technology.

Collaborations: Bo Peng has collaborated with top researchers from renowned universities such as MIT and Harvard, fostering a culture of innovation and knowledge-sharing in the academic and corporate sectors.

Conclusion: Bo Peng's dedication to pushing the boundaries of technology and his passion for creating solutions to complex problems make him a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…